Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Kinome expression profiling to target new therapeutic avenues in multiple myeloma

9 Jul 2019

Abstract excerpt

Multiple myeloma (MM) account for approximately 10% of hematological malignancies and is the second most common hematological disorder. Kinases inhibitors are widely used and their efficiency for the treatment of cancers has been demonstrated. Here, in order to identify kinases of potential therapeutic interest for the treatment of MM, we investigated the prognostic impact of the kinome expression profile in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Multiple Myeloma Research and Treatments
Share to Protein Degradation and Inhibitors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31289205
DOI: 10.3324/haematol.2018.208306

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Kinome expression profiling to target new therapeutic avenues in multiple myelomaPMID 31289205Read ↗

Gene expression profiling defines a high-risk entity of multiple myeloma.Semantic proximity Read ↗

Bruton’s Tyrosine Kinase Targeting in Multiple MyelomaSemantic proximity Read ↗

Identification of extracellular matrix-related prognostic biomarkers and their role associated with multiple myelomaSemantic proximity Read ↗

Identification of candidate therapeutics and signaling pathways for multiple myelomaSemantic proximity Read ↗

Mitophagy-related gene signature for predicting the prognosis of multiple myelomaSemantic proximity Read ↗

Phosphoinositide Protein Kinase PDPK1 Is a Crucial Cell Signaling Mediator in Multiple MyelomaSemantic proximity Read ↗

Single-cell sequencing analysis of multiple myeloma heterogeneity and identification of new theranostic targetsSemantic proximity Read ↗

Genome-Wide Identification of Potential Biomarkers in Multiple Myeloma Using Meta-Analysis of mRNA and miRNA Expression DataSemantic proximity Read ↗

How to use new biology to guide therapy in multiple myeloma.Semantic proximity Read ↗

Single-cell sequencing analysis of multiple myeloma heterogeneity and identification of new theranostic targetsSemantic proximity Read ↗

PIM2 Kinase Regulates TIGIT Expression and Function in NK Cells from Multiple Myeloma PatientsSemantic proximity Read ↗

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.